As a consequence, comparable to the lipodystrophy models A/ZIP and aP2-SREBP-1c [65,66], hyperinsulinemia, hyperglycemia and hepatic steatosis occurs here, even if the mechanism here is not directly mediated by SREBP-1. This evidence concerns the gene SREBF1 and fatty liver disease.